 |
|
New patient satisfaction study with budesonide/formoterol combination therapy
May 21, 2008A new open-label study evaluated patient satisfaction with budesonide/formoterol combination therapy and fluticasone/salmeterol combination therapy, as measured by the Asthma Treatment Satisfaction Measure (ATSM).1 Patients participating in the study were ages 18 years and older with moderate to severe asthma and had been previously treated with inhaled corticosteroids.1 Results were presented today at the International Conference of the American Thoracic Society held in Toronto, May 16-21, 2008.
Results showed that patients receiving budesonide/formoterol combination therapy administered as adjustable dosage reported significantly greater satisfaction on the ATSM overall (p=0.02) than patients receiving fluticasone/salmeterol combination therapy, especially in the categories of feel medication begins to work (p<0.001), dosing management (p<0.001), and timely relief of symptoms (p=0.037).1 Patients receiving budesonide/formoterol combination therapy fixed dose reported significantly greater satisfaction for timely relief of symptoms (p=0.002) and feeling the medication begin to work (p=0.02) compared to patients receiving fluticasone/salmeterol combination therapy.1 Budesonide/formoterol combination therapy is not indicated for adjustable dosing in the U.S.
"These data showed that patients treated with budesonide/formoterol combination therapy fixed dose were more satisfied with the timeliness of their symptom relief than those patients treated with fluticasone/salmeterol combination therapy," said lead investigator Richard O'Connor, MD, of the University of California-San Diego.
Edelman Public Relations
Edelman Public Relations
Combination Therapy Current Events and Combination Therapy News RSSIneffective monotherapies common in high-burden malarious countries
ACTwatch, a research project led by PSI, in collaboration with the London School of Hygiene and Tropical Medicine, released evidence today that indicates that artemisinin combination therapy, the most effective medicines for treating malaria, continue to have a significantly low presence on the market among populations considered to be most at risk.
'Difficult-to-treat asthma' may be due to difficult-to-treat patients
Difficult-to-treat asthma often may have more to do with patients who do not take their medication as instructed than ineffective medication, according to researchers in Northern Ireland.
Study examines treatment for olfactory loss after viral infection
Treatment with a glucocorticoid medication, either alone or in combination with Ginkgo biloba, appears to significantly improve the sense of smell in individuals with previous olfactory loss due to upper respiratory infections.
Breast tenderness during hormone replacement therapy linked to elevated cancer risk
Women who developed new-onset breast tenderness after starting estrogen plus progestin hormone replacement therapy were at significantly higher risk for developing breast cancer than women on the combination therapy who didn't experience such tenderness, according to a new UCLA study.
Self-monitoring of blood glucose
Diabetes patients should always control their own blood sugar values if this leads to improvements in their treatment.
Diabetes drug kills cancer stem cells in combination treatment in mice
In a one-two punch, a familiar diabetes drug reduced tumors faster and prolonged remission in mice longer than chemotherapy alone by targeting cancer stem cells, Harvard Medical School researchers reported in the September 14 online first edition of Cancer Research, a journal of the American Association for Cancer Research.
Men experience sexual dysfunction during hepatitis C therapy
Sexual impairment is common among men with chronic hepatitis C undergoing antiviral therapy, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association (AGA) Institute.
Chemotherapy resistance: Checkpoint protein provides armor against cancer drugs
Cell cycle checkpoints act like molecular tripwires for damaged cells, forcing them to pause and take stock.
Hepatitis C virus channels efforts into cell survival
Researchers at the University of Leeds have discovered a previously unknown mechanism that allows the hepatitis C virus (HCV) to remain in the body for decades.
New strategy in tumor treatment
A new strategy proposed by researchers at Dartmouth Medical School and Amtek, Hanover, NH may treat tumors that do not respond to conventional treatment.
More Combination Therapy Current Events and Combination Therapy News Articles
|
Targeted Cancer Therapy (Current Clinical Oncology) by Razelle Kurzrock (Editor), Maurie Markman (Editor) In the era of personalized medicine, cancer treatment has become a model for the use of targeted therapeutics. Leaving behind the "one size fits all" approach to cancer care, this book provides the practicing oncologist with an overview of the advances in treatment and an understanding of the implementation of new therapeutic agents. Targeted Cancer Therapy is divided into twenty chapters covering specific hematologic malignancies and solid tumors, targeted and functional imaging, and combination therapies. Each disease specific chapter includes up-to-date information on investigational and FDA approved therapies which will enhance the reader’s ability to prescribe effective drug regimens. This includes combinations of therapies and therapeutic modalities to overcome drug... | |
 |
Kinerase Pro+Therapy Lotion with Kinetin & Zeatin 2.8 Ounces (80ml) Tube by Kinerase A professionals-only skin care line, Kinerase Pro+Therapy lotion with the combination of kinetin and zeatin works to help improve the appearance of fine lines and wrinkles. It also helps improve the appearance of skin texture, tone, and blotchiness in sun damaged skin, while gently moisturizing dry and sensitive or post-procedure skin. Studies have shown that zeatin improves the appearance of fine lines and wrinkles, skin roughness, and hyperpigmentation and only zeatin has also been clinically shown to improve the appearance of the more severe signs of skin aging after only 8 weeks. |
 |
Therapy Systems Glycolic Cleansing Gel by Therapy Systems This head to toe cleanser is formulated with the highest level of active glycolic acid to decongest the pores, accelerate cellular regeneration and refine skin texture. Glycolic Cleansing Gel's low lather guarantees deep cleansing for all skin types, especially those with oilier tendencies. |
 |
Single Patient Cord for Combination Ultrasound / Muscle Stimulator Therapy by Mettler Electronics Cord for use with the Sys*Stim® 226 Muscle Stimulator, the Sys*Stim® 294 Muscle Stimulator, the Sonicator® Plus 992 Combination Ultrasound / Muscle Stimulator Unit or the Sonicator® Plus 994 Combination Ultrasound / Muscle Stimulator Unit. |
 |
SoftSpot® Proline Removable "Squeeze Therapy" Mouse Pad & Wrist Rest, Black (SAF90108) Category: Mouse Pad and Wrist Rest Combinations by Safco SoftSpot® Proline Removable "Squeeze Therapy" Mouse Pad and Sculpted Wrist Rest Pads can be removed to double as squeeze-exercise devices. Therasoft® cushioning material is nonabrasive, durable and antistatic. Includes an illustrated exercise guide with a program to relax muscles and stimulate circulation. Wrist rest removes for muscle stretching and strengthening exercises. 7-1/2w x 13d x 1-5/16h. Black |
 |
Garba Raksha (Pregnant Women) by Health Therapy Series A collection of chants and mantras specially selected to help carry a healthy and absolutely vital pregnancy. By bringing the emotions under control through changes in the brainwave pattern, both in the morning and evening, expectant mothers are relived of stress, in turn creating a nurturing environment for the fetus. |
 |
Combination of TENS and EMS Unit - Best TENS Unit - with Carrying Case, Electrodes, and Battery Included by Pro Therapy Supplies 2 Channel, 3 Mode Digital Combo TENS/NMESChannels: Dual, IsolatedOutput Voltage: 0-40 V (500O load)Output Intensity: 0-80mA (500O load)Waveform: Asymmetrical biphasic rectangularPulse Rate: 1-150 Hz, 45 adjustable stepsPulse Width: 30-300 S, 10S per stepOn Ramp: 1-6 secondsCycle ON Time: 1-30 secondsCycle OFF Time: 1-30 secondsTreatment Timer: 1-60 minutesCompliance Monitor: Records accumulated time from0-999 minutesBattery: 9 Volt alkaline or rechargeableDimensions: 95 x 60 x 25 mmWeight: 90g (battery included)Tolerence: 20% |
|
Triple therapy reduces primary stroke severity: the combination of antiplatelet therapy, statins, and ACE inhibitors also led to better outcomes.(Neurology): An article from: Internal Medicine News by Damian McNamara (Author) This digital document is an article from Internal Medicine News, published by Thomson Gale on July 1, 2005. The length of the article is 501 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: Triple therapy reduces primary stroke severity: the combination of antiplatelet therapy, statins, and ACE inhibitors also led to better outcomes.(Neurology) Author: Damian McNamara Publication: Internal Medicine News (Magazine/Journal) Date: July 1, 2005 Publisher: Thomson Gale Volume: 38 Issue: 13 Page: 16(1) Distributed by Thomson... | |
|
Insulin/Sulphonylurea: Combination Therapy in Type II Diabetes/2nd Symposium on Insulin/Sulphonylurea Combination Therapy in Type II Diabetes, Munic by W. Bachmann (Author), N. Lotz (Author), H. Mehnert (Editor) | |
 |
Expert Opinions on Contemporary Clinical Issues in Hepatitis C (Part One) (NCME Video 760) Also With: Network For Continuing Medical Education (Primary Contributor), Willis C. Maddrey (Primary Contributor), Eugene R. Schiff (Primary Contributor) Important lessons regarding relapse and its prevention and treatment were learned from managing chronic hepatitis C virus (HCV) infections with monotherapy. It now appears that some of these lessons may be applicable with combination therapy. In addition, many clinicians and investigators now question whether these other populations, such as interferon nonresponders, might also benefit from combination therapy. In Read more Important lessons regarding relapse and its prevention and treatment were learned from managing chronic hepatitis C virus (HCV) infections with monotherapy. It now appears that some of these lessons may be applicable with combination therapy. In addition, many clinicians and investigators now question whether these other populations, such as interferon nonresponders,... |
| © 2009 BrightSurf.com |